OrganiGram Holdings (OGI) stock forecast for 2024

The forecast has been updated: September 24, 2022 5:34


OrganiGram Holdings stock price online today

Analyst Target Price

2.55

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell OrganiGram Holdings stock stock today? What is the projected target price level for 2024? How much will it cost in 2024? OrganiGram Holdings stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2024.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $2.55 target price for OrganiGram Holdings stock stock.

Today 200 Day Moving Average is the resistance level (1.366 $).

50 Day Moving Average is the resistance level (1.077 $).




OGI Forecast for 2024

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 1.26 1.20 1.41 14.55 %
Feb 1.42 1.24 1.55 20.05 %
Mar 1.43 1.29 1.52 15.38 %
Apr 1.55 1.42 1.72 17.57 %
May 1.69 1.50 1.83 17.89 %
Jun 1.70 1.53 1.91 19.57 %
Jul 1.69 1.55 1.82 15.04 %
Aug 1.46 1.37 1.62 15.73 %
Sep 1.70 1.50 1.86 19.49 %
Oct 1.60 1.39 1.80 23.02 %
Nov 1.66 1.53 1.89 19.32 %
Dec 1.66 1.55 1.77 12.51 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of OrganiGram Holdings stock.


OrganiGram Holdings overview

OrganiGram Holdings Address

35A ENGLISH DR., MONCTON, NB, CA

Market Capitalization

317 211 000 $

EBITDA

-12 559 000

PE Ratio

None

PEG Ratio

None

Dividend Per Share

0

Dividend Yield

0

EPS

-0.091

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

0.875

Trailing PE

-

Forward PE

28.99

EV To Revenue

1.812

EV To EBITDA

-663.25

52 Week High

2.55

52 Week Low

0.871

50 Day Moving Average

1.077

200 Day Moving Average

1.366

Shares Outstanding

313708000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

OrganiGram Holdings stock forecast for this year


OrganiGram Holdings stock forecast for Jan 2024.
Estimated Average Forecasted OrganiGram Holdings Price: 1.26. Negative monthly dynamics of the instrument is expected with 14.550% volatility is expected.

Pessimistic forecast: 1.20

Optimistic: 1.41


OrganiGram Holdings stock forecast for Feb 2024.
Estimated Average Forecasted OrganiGram Holdings Price: 1.42. Positive monthly dynamics of the instrument is expected with 20.047% volatility is expected.

Pessimistic forecast: 1.24

Optimistic: 1.55


OrganiGram Holdings stock forecast for Mar 2024.
Estimated Average Forecasted OrganiGram Holdings Price: 1.43. Positive monthly dynamics of the instrument is expected with 15.383% volatility is expected.

Pessimistic forecast: 1.29

Optimistic: 1.52


OrganiGram Holdings stock forecast for Apr 2024.
Estimated Average Forecasted OrganiGram Holdings Price: 1.55. Positive monthly dynamics of the instrument is expected with 17.574% volatility is expected.

Pessimistic forecast: 1.42

Optimistic: 1.72


OrganiGram Holdings stock forecast for May 2024.
Estimated Average Forecasted OrganiGram Holdings Price: 1.69. Positive monthly dynamics of the instrument is expected with 17.894% volatility is expected.

Pessimistic forecast: 1.50

Optimistic: 1.83


OrganiGram Holdings stock forecast for Jun 2024.
Estimated Average Forecasted OrganiGram Holdings Price: 1.70. Positive monthly dynamics of the instrument is expected with 19.565% volatility is expected.

Pessimistic forecast: 1.53

Optimistic: 1.91


OrganiGram Holdings stock forecast for Jul 2024.
Estimated Average Forecasted OrganiGram Holdings Price: 1.69. Negative monthly dynamics of the instrument is expected with 15.036% volatility is expected.

Pessimistic forecast: 1.55

Optimistic: 1.82


OrganiGram Holdings stock forecast for Aug 2024.
Estimated Average Forecasted OrganiGram Holdings Price: 1.46. Negative monthly dynamics of the instrument is expected with 15.733% volatility is expected.

Pessimistic forecast: 1.37

Optimistic: 1.62


OrganiGram Holdings stock forecast for Sep 2024.
Estimated Average Forecasted OrganiGram Holdings Price: 1.70. Positive monthly dynamics of the instrument is expected with 19.490% volatility is expected.

Pessimistic forecast: 1.50

Optimistic: 1.86


OrganiGram Holdings stock forecast for Oct 2024.
Estimated Average Forecasted OrganiGram Holdings Price: 1.60. Negative monthly dynamics of the instrument is expected with 23.020% volatility is expected.

Pessimistic forecast: 1.39

Optimistic: 1.80


OrganiGram Holdings stock forecast for Nov 2024.
Estimated Average Forecasted OrganiGram Holdings Price: 1.66. Positive monthly dynamics of the instrument is expected with 19.317% volatility is expected.

Pessimistic forecast: 1.53

Optimistic: 1.89


OrganiGram Holdings stock forecast for Dec 2024.
Estimated Average Forecasted OrganiGram Holdings Price: 1.66. Negative monthly dynamics of the instrument is expected with 12.510% volatility is expected.

Pessimistic forecast: 1.55

Optimistic: 1.77



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 98.72 (28.09.2022) 0.40 %
AbbVie Inc.
ABBV 144.6 (28.09.2022) 2.03 %
Aeterna Zentaris Inc.
AEZS 3.92 (28.09.2022) 3.16 %
Allakos Inc.
ALLK 5.77 (28.09.2022) 11.82 %
Allogene Therapeutics, Inc.
ALLO 11.43 (28.09.2022) 1.51 %
Amgen Inc.
AMGN 230.98 (28.09.2022) 2.21 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 3.84 (28.09.2022) 15.32 %
Aurora Cannabis Inc.
ACB 1.3 (28.09.2022) 7.44 %
Becton Dickinson and Company
BDX 230.37 (28.09.2022) 0.89 %
Biogen Inc.
BIIB 276.61 (28.09.2022) 39.85 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 151.93 (28.09.2022) -0.18 %
BioNTech SE
BNTX 133.79 (28.09.2022) 2.68 %
bluebird bio, Inc.
BLUE 5.77 (28.09.2022) 5.87 %
Boston Scientific Corp.
BSX 39.13 (28.09.2022) 2.60 %
Bristol-Myers Squibb Company
BMY 72.06 (28.09.2022) 2.42 %
Canopy Growth Corp.
CGC 3.04 (28.09.2022) 6.29 %
Castle Biosciences, Inc.
CSTL 26.09 (28.09.2022) 9.71 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 242.27 (04.02.2022) 0.00 %
Emergent BioSolutions Inc.
EBS 21.33 (28.09.2022) 3.90 %
Exelixis, Inc.
EXEL 18.56 (17.06.2022) 5.63 %
G1 Therapeutics, Inc.
GTHX 12.89 (28.09.2022) 6.35 %
Gilead Sciences, Inc.
GILD 63.93 (28.09.2022) 2.08 %
GlaxoSmithKline plc
GSK 29.46 (28.09.2022) 2.79 %
GoodRx Holdings, Inc.
GDRX 5.1 (28.09.2022) 1.39 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 67.66 (28.09.2022) 1.84 %
Inovio Pharmaceuticals, Inc.
INO 1.84 (28.09.2022) 4.55 %
Johnson & Johnson
JNJ 166.36 (28.09.2022) 0.86 %
Medtronic plc.
MDT 82.59 (28.09.2022) 2.10 %
Merck & Co., Inc.
MRK 86.78 (28.09.2022) 1.10 %
Moderna, Inc.
MRNA 122.15 (28.09.2022) -0.07 %
Novartis AG
NVS 76.32 (28.09.2022) 2.24 %
Novavax, Inc.
NVAX 19.61 (28.09.2022) -2.15 %
ObsEva SA
OBSV 0.147 (28.09.2022) 4.85 %
OrganiGram Holdings Inc.
OGI 0.9338 (28.09.2022) 4.35 %
Pfizer Inc.
PFE 44.43 (28.09.2022) 0.77 %
Regeneron Pharmaceuticals, Inc.
REGN 705.42 (28.09.2022) 1.50 %
Sanofi
SNY 38.17 (28.09.2022) 2.55 %
Schrodinger, Inc.
SDGR 25.69 (28.09.2022) 6.51 %
Senseonics Holdings, Inc.
SENS 1.39 (28.09.2022) 4.51 %
Sorrento Therapeutics, Inc.
SRNE 1.69 (28.09.2022) 9.03 %
Stryker Corp.
SYK 205.82 (28.09.2022) 1.55 %
Sundial Growers Inc.
SNDL 2.37 (28.09.2022) 5.80 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 7.96 (28.09.2022) 2.84 %
Thermo Fisher Scientific Inc.
TMO 517.83 (28.09.2022) 1.80 %
Tilray, Inc.
TLRY 3.01 (28.09.2022) 7.50 %
UnitedHealth Group, Inc.
UNH 513.94 (28.09.2022) 1.10 %
Veeva Systems Inc.
VEEV 164.72 (28.09.2022) 2.16 %
Zomedica Corp.
ZOM 0.2198 (28.09.2022) 3.73 %
Zynerba Pharmaceuticals, Inc.
ZYNE 0.8604 (28.09.2022) 1.18 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.